LBPHLongboard PharmaceuticalsLBPH info
$29.31info6.27%24h
Global rank8030
Market cap$965.37M
Change 7d-
YTD Performance58.60%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Longboard Pharmaceuticals (LBPH) Stock Overview

    Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. to develop and commercialize LP352, LP659, LP143, and other compounds. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

    LBPH Stock Information

    Symbol
    LBPH
    Address
    4275 Executive SquareLa Jolla, CA 92037United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.longboardpharma.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    619 592 9775

    Longboard Pharmaceuticals (LBPH) Price Chart

    -
    Value:-

    Longboard Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $29.31
    N/A
    Market Cap
    $965.37M
    N/A
    Shares Outstanding
    32.94M
    N/A
    Employees
    32.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org